These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4961207)

  • 21. Influence of ethyl p-chlorophenoxyisobutyrate (CPIB) upon establishment and progression of experimental atherosclerosis in rabbits.
    Kritchevsky D; Sallata P; Tepper SA
    J Atheroscler Res; 1968; 8(5):755-61. PubMed ID: 5688373
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of chlorphenisate on serum lipids].
    Cisternas H; Arteaga A; Allende ME
    Rev Med Chil; 1968 Nov; 96(11):723-8. PubMed ID: 5714889
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
    Tomita T; Takeshita R; Nagakura T; Hayashi E
    Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of clofibrate on platelet economy in man.
    Glynn MF; Murphy EA; Mustard JF
    Lancet; 1967 Aug; 2(7513):447-8. PubMed ID: 4166108
    [No Abstract]   [Full Text] [Related]  

  • 25. THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH; STRISOWER B
    J Clin Endocrinol Metab; 1964 Feb; 24():139-44. PubMed ID: 14123837
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical changes in rat liver in response to treatment with drugs and other agents. I. Effects of anticonvulsant, anti-inflammatory, hypocholesterolaemic and adrenergic beta-blocking agents.
    Platt DS; Cockrill BL
    Biochem Pharmacol; 1969 Feb; 18(2):429-44. PubMed ID: 4305094
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of the ethyl ester and sodium salt of alpha-p-chlorophenoxyisobutyric acid on cholesterol oxidation by rat liver mitochondria.
    Kritchevsky D; Tepper SA; Sallata P; Kabakjian JR; Cristofalo VJ
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):79-82. PubMed ID: 5344871
    [No Abstract]   [Full Text] [Related]  

  • 28. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    BEST MM; DUNCAN CH
    J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
    [No Abstract]   [Full Text] [Related]  

  • 29. Growth and liver glycerophosphate dehydrogenase response to thyroxine and p-chlorophenoxyisobutyrate.
    Richert DA; Westerfeld WW
    Endocrinology; 1970 Dec; 87(6):1274-81. PubMed ID: 5529883
    [No Abstract]   [Full Text] [Related]  

  • 30. Appraisal of clofibrate as a hypolipidemic agent.
    Sachs BA
    Am Heart J; 1968 May; 75(5):707-10. PubMed ID: 5645992
    [No Abstract]   [Full Text] [Related]  

  • 31. Rat hepatic polysome profiles and in vitro protein synthesis during hypoxia.
    Surks MI; Berkowitz M
    Am J Physiol; 1971 Jun; 220(6):1606-9. PubMed ID: 5087807
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of ethyl-p-chlorophenoxyisobutyrate, clofibrate, on the plasma and red blood cell free fatty acids of the rat.
    Cenedella RJ; Jarrell JJ; Saxe LH
    J Atheroscler Res; 1968; 8(6):903-11. PubMed ID: 5707796
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of biguanides and atromid on fibrinolysis.
    Hocking ED; Chakrabarti R; Evans J; Fearnley GR
    J Atheroscler Res; 1967; 7(2):121-30. PubMed ID: 6034469
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic effects of dehydroepiandrosterone and Atromid in patients with hyperlipaemia.
    Felt V; Stárka L
    Cor Vasa; 1966; 8(1):40-8. PubMed ID: 4160021
    [No Abstract]   [Full Text] [Related]  

  • 35. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
    Timms AR; Kelly LA; Ho RS; Trapold JH
    Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of hydrazine treatment on hepatic protein biosynthesis in vivo.
    Banks WL
    Biochem Pharmacol; 1970 Jan; 19(1):275-83. PubMed ID: 5507641
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemical pathology of acute amino acid deficiencies: reversibility of the pathologic changes in rats force-fed a threonine-devoid diet.
    Verney E; Sidransky H
    J Nutr; 1971 Dec; 101(12):1727-36. PubMed ID: 5126265
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of p-chlorophenoxyisobutyric acid, ethyl p-chlorophenoxyisobutyrate, and Atromid on the synthesis of nonsaponifiable material and cholesterol in the bovine aorta.
    Teal SW; Gamble W
    Biochem Pharmacol; 1965 May; 14(5):896-8. PubMed ID: 5840738
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
    Kokatnur MG; Malcom GT
    Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical changes in rat liver after administration of carbon disulphide, with particular reference to microsomal changes.
    Bond EJ; De Matteis F
    Biochem Pharmacol; 1969 Oct; 18(10):2531-49. PubMed ID: 5403989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.